Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics - GBI Research Reports

Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics

Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics - GBI Research Reports
Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics
Published Jun 25, 2011
81 pages — Published Jun 25, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Researchs new report, Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics provides key data, information and analysis on the Orthobiologics industry and analytical content on the market dynamics. The report provides market landscape, competitive landscape and market trends information on Orthobiologics industry . The report provides comprehensive information on the current practices and trends in the Orthobiologics industry. The report also reviews the competitive landscape, and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Market size and company share data for Orthobiologics.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009..
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the Orthobiologics market.
- The report also covers information on the leading market players, the competitive landscape, and the leading technologies.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the Orthobilogics market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Whats the next being thing in the Orthobilogics market? Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global Orthobilogics market and the factors shaping it.

  
Source:
Document ID
GBIME0028MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents34
  List of Tables51
  List of Figures61
Introduction71
  GBI Research Guidance71
Overview: Orthobiologics82
  Applications of Orthobiologics82
Global Orthobiologics : Market Characterization107
  Global Orthobiologics Market, Revenue ($m), 2002 2009102
  Global Orthobiologics Market, Revenue Forecast ($m), 2009 2016121
  Global Orthobiologics Market, Key Company Shares (%), 2009132
  Global Orthobiologics Market, Dynamics151
    Market Drivers151
      Increasing Incidence of Arthritis and Other Orthopaedic Diseases Due to an Ageing Population and Obesity will Drive Future Growth of Orthobiologics151
      Technological Advances and Large Number of Products in the Pipeline is Expected to Drive the Growth of Orthobiologics151
      Increasing Number of Sports Injuries and Road Accidents to Drive Growth in Orthobiologics Market161
      Government Initiatives such as the Healthcare Reform Act and the Delay of Retirement to Drive the Orthobiologics Market161
    Market Restraints161
      Shortage of Surgeons Restricting the Number of Procedures161
Global Orthobiologics Market: Category Analysis and Forecasts1714
  Global Bone Graft Substitutes Market, Revenue ($m), Historic, 2002 2009171
  Global Bone Graft Substitutes Market, Revenue ($m), Forecast, 2009 2016181
    Bone Graft Substitutes, Market Drivers191
      Increasing Demand for Synthetic Bone Graft Substitutes to Bolster Market Growth191
      Increasing Applications for Bone Graft Substitutes to Drive Growth191
      Increasing Incidence of Degenerative Disc Disease and Increasing Number of Fusion Procedures to Drive the Growth of Bone Graft Substitutes191
    Bone Graft Substitutes, Market Restraint191
      Safety Concerns over Bone Morphogenetic Protein (BMP) in Spinal Fusion Surgeries and High Cost is slowing the Adoption191
  Global Viscosupplementation Market, Revenue ($m), Historic, 2002 2009201
  Global Viscosupplementation Market, Revenue ($m), Forecast, 2009 2016211
    Viscosupplementation, Market Drivers221
      New Products with Lower Complication Rates and Lower Costs to Drive Demand221
      Limited Scope of Drugs to Treat End Stage Osteoarthritis to Drive Market for Viscosupplementation221
      Expansion of Applications to Other Osteoarthritis Affected Joints to Drive the Market221
    Viscosupplementation, Market Restraint221
      Pricing Challenges to Continue to Plague the Viscosupplementation Market221
  Global DBM Market, Revenue ($m), Historic, 2002 2009231
  Global DBM Market, Revenue ($m), Forecast, 2009 2016241
    DBM, Market Drivers251
      Advances in DBM Products over the Past Few Years have resulted in Increasing Adoption251
      The Success of DBM to Induce Bone Formation in Various Clinical Conditions will Increase Adoption251
    DBM, Market Restraint251
      Several Potential Disadvantages Such as the Potential to Transmit Human Immunodeficiency Virus May Act as a Restraint on Market Growth251
  Global Bone Growth Stimulators Market, Revenues ($m), Historic, 2002 2009261
  Global Bone Growth Stimulators Market, Revenues ($m), Forecast, 2009 2016271
    Bone Growth Stimulators, Market Driver281
      Increasing Number of Fractures due to Ageing is Expected to Drive the Market Growth for Bone Growth Stimulators281
    Bone Growth Stimulators, Market Restraint281
      Lack of Exact Knowledge about the Mechanism of Action for These Devices and Lack of Studies in Specific Patient Groups will Restrict their Adoption281
  Global Bone Allografts Market, Revenue ($m), Historic, 2002-2009291
  Global Bone Allografts Market, Revenue ($m), Forecast, 2009-2016301
Global Orthobiologics Market: Country Analysis and Forecasts3124
  Historic (2002 2009) and Forecast (2009-2016) Revenue, By Country311
    Orthobiologics Market, the US, Revenue ($m), 2002 2009311
    Orthobiologics Market, the US, Revenue ($m), 2009 2016321
    Orthobiologics Market, Canada, Revenue ($m), 2002 2009331
    Orthobiologics Market, Canada, Revenue ($m), 2009 2016341
    Orthobiologics Market, the UK, Revenue ($m), 2002 2009351
    Orthobiologics Market, the UK, Revenue ($m), 2009 2016361
    Orthobiologics Market, Germany, Revenue ($m), 2002 2009371
    Orthobiologics Market, Germany, Revenue ($m), 2009 2016381
    Orthobiologics Market, France, Revenue ($m), 2002 2009391
    Orthobiologics Market, France, Revenue ($m), 2009 2016401
    Orthobiologics Market, Italy, Revenue ($m), 2002 2009411
    Orthobiologics Market, Italy, Revenue ($m), 2009 2016421
    Orthobiologics Market, Spain, Revenue ($m), 2002 2009431
    Orthobiologics Market, Spain, Revenue ($m), 2009 2016441
    Orthobiologics Market, Brazil, Revenue ($m), 2002 2009451
    Orthobiologics Market, Brazil, Revenue ($m), 2009 2016461
    Orthobiologics Market, Japan, Revenue ($m), 2002 2009471
    Orthobiologics Market, Japan, Revenue ($m), 2009 2016481
    Orthobiologics Market, China, Revenue ($m), 2002 2009491
    Orthobiologics Market, China, Revenue ($m), 2009 2016501
    Orthobiologics Market, India, Revenue ($m), 2002 2009511
    Orthobiologics Market, India, Revenue ($m), 2009 2016521
    Orthobiologics Market, Australia, Revenue ($m), 2002 2009531
    Orthobiologics Market, Australia, Revenue ($m), 2009 2016541
Global Orthobiologics Market: Competitive Assessment556
  Medtronic Inc.551
    Overview:551
      Pipeline Products551
  Genzyme Corporation561
    Overview561
      Marketed Products561
  Depuy, Inc.(Johnson &Johnson)561
    Overview561
      Marketed Products561
      Pipeline Products561
  Synthes, Inc.571
    Overview571
      Marketed Products571
  Smith &Nephew Plc581
    Overview581
      Marketed Products581
      Pipeline Products581
  Stryker591
    Overview591
      Marketed Products591
      Pipeline Products591
  Orthofix International N.V601
    Overview601
      Marketed Products601
      Pipeline Products601
Global Orthobiologics Market: Product Pipeline Analysis6112
  Orthobiologics Market: Pipeline Products Summary612
  Profiles of Promising Products Under Clinical Development:631
    Synthetic Bone Graft Substitutes631
      Augment Bone Graft (BioMimetic Therapeutics, Inc.)631
      Injectable Bone Graft/Scaffold (BioTech One Inc)641
      NanoFUSE Bone Graft (Nanotherapeutics, Inc.)641
      ST01 Bone Graft Substitute Material (Scil Technology Gmbh)641
      Structural Synthetic Bonegraft (Kensey Nash Corporation)641
    BMP651
      Amplify rhBMP-2 (Medtronic, Inc.)651
      BioChaperone BMP - Degenerative Disc Disease (Adocia)661
      BMP-7-Osteoarthritis (Stryker Corporation)661
      Infuse Bone Graft Posterolateral Fusions (Medtronic, Inc.)661
    Bone Growth Stimulators661
      Nanosurfaced Biomaterials - Closed Bone Augmentation (Nanovis Incorporated)661
      Hyaloss (Anika Therapeutics, Inc.)661
      Osteocel XC (Osiris Therapeutics, Inc.)671
      Osteoinductive Coating for Metallic Devices (Inion Oy)671
      Osteorate (Cardium Therapeutics, Inc.)671
      VeriCart671
    Bone Allograft681
      CR-Plug (RTI Biologics, Inc.)681
      OsteoAMP-putty (Advanced Biologics LLC)681
      OsteoAMP-sponge (Advanced Biologics LLC)681
    Viscosupplementation681
      Durolane (Q-Med AB)681
      Monovisc (Anika Therapeutics, Inc.)681
      CINGAL (Anika Therapeutics, Inc.)681
    DBM691
      Origen DBM (Orthofix International N.V.)691
      Super-inductive DBM (RTI Biologics, Inc.)691
  List of Pipeline Products691
    Pipeline Product Summary694
Global Orthobiologics Market: Consolidation Landscape735
  Key Deals751
    Medtronic to Acquire Osteotech751
      Strategic Rationale:751
    Landec Acquires Lifecore Biomedical751
      Strategic Rationale:761
    Baxter International Completes Acquisition Of ApaTech761
      Strategic Rationale:761
    TiGenix Completes Acquisition Of OrthoMimetics761
      Strategic rationale:761
    NuVasive Invests In Progentix Orthobiology761
      Strategic Rationale:771
    Kinetic Concepts Acquires LifeCell771
      Strategic Rationale:771
    Pioneer Surgical Acquires Angstrom Medica771
      Strategic Rationale:771
    Pioneer Surgical Technology Acquires Encelle771
      Strategic Rationale:771
    Orthofix Acquires Blackstone Medical771
      Strategic rationale:771
Appendix784
  Definitions781
    Orthobiologics781
      Bone Allografts781
      Bone Graft Substitute781
      Bone Growth Stimulators781
      DBM781
      Viscosupplementation781
  Acronyms781
  Sources791
  Research Methodology792
    Secondary Research791
    Primary Research791
    Models801
    Forecasts801
    Expert Panels801
  Contact Us811
  Disclaimer811

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics" Jun 25, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Orthobiologics-Market-to-2016-Alternatives-to-Surgery-and-Superior-Outcomes-are-Driving-Wider-Adoption-of-Orthobiologics-2115-189>
  
APA:
GBI Research Reports. (2011). Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics Jun 25, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Orthobiologics-Market-to-2016-Alternatives-to-Surgery-and-Superior-Outcomes-are-Driving-Wider-Adoption-of-Orthobiologics-2115-189>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.